Afamitresgene autoleucel (afami-cel; formerly ADP-A2M4) demonstrates durable clinical responses by inducing broad immune engagement with anti-tumor activity-MedSci.cn

Afamitresgene autoleucel (afami-cel; formerly ADP-A2M4) demonstrates durable clinical responses by inducing broad immune engagement with anti-tumor activity

McAlpine, C; Isabelle, M; Broad, R; Naidoo, R; Liddle, A; Duperret, E; Noto, P; Wang, RX; Batrakou, D; Middha, S; Evans, C

CANCER RESEARCH, 2023; 83 (7):

科室
- - 订阅+
  - 更多科室
工具
服务